pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat and rare cancers.

LOCATION

  • Palo Alto, CA, USA

    • THERAPEUTIC AREAS

  • Oncology

    • WEBSITE

    https://navirepharma.com/

    CAREER WEBSITE

    None

    SOCIAL MEDIA

    INVESTORS

    bridgebio-pharma

    PRESS RELEASES


    Nov 13, 2020

    BridgeBio Pharma and Affiliate Navire Pharma Announce Dosing of First Patient in Phase 1 Clinical Trial of SHP2 inhibitor BBP-398 for Tumors Driven by RAS and Receptor Tyrosine Kinase Mutations


    For More Press Releases
    Google Analytics Alternative